 |
| HOME |
| ABOUT US |
| OUR SCIENCE |
| MARKETS |
| NEWS |
| CONTACT US |
|
|
Markets |
|
|
|
|
Ganeden's unique, patented probiotic bacteria, coupled with our science based approach to probiotic product development, allows for unique market applications that otherwise pose significant technological challenges, making many applications altogether impossible. Ganeden's probiotic organisms have been used to develop products in markets such as:
Ganeden Biotech's state-of-the-art research and development laboratory, located in Miami, FL, is one of the most advanced probiotic research laboratories in the world. Fully equipped to provide high throughput strain identification and characterization, strain isolation, bacterial enumeration, product testing and product development services to support even the most complex needs of our licensing partners.
Feel free to Contact Us to discuss your unique product development needs.
|
|
|
Market News |
|
|
|
|
U.S. sales of probiotics are estimated at $764 million in 2005 and are expected to rise at an average annual growth rate (AAGR) of 7.1% to $1.1 billion in 2010.
Probiotics used in the manufacture of supplements are projected to reach $291.4 million in 2010, representing an AAGR of 6.7%.
Food applications dominate the markets and sales are estimated at $498 million in 2005 and will rise at an AAGR of 7% to $700 in 2010.
|
|
|
|
|
Featured Products |
|
|
|
|
|
|
|
